2019 nCoV/COVID19 Nucleocapsid Recombinant

Products_type

Recombinant Protein
Products_short_name

[COVID 19 Nucleocapsid (NP) Coronavirus]
Products_name_syn

[2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Nucleocapsid; Nucleoprotein (NP)]
Products_gene_name

[COVID-19]
Products_gene_name_syn

[2019-nCoV; SARS-CoV-2; SARS coronavirus 2 proteome; COVID19; SARS-CoV2]
Purity

>95%, by SDS-PAGE
Form

Lyophilized from sterile solution of pH 7.4
Storage_stability

Lyophilized at -20 degree C for 24 months.Lyophilized at ambient temperature for 3 weeks.Reconstituted at -20 degree C for 12 months.Reconstituted at 2-8 degree C for 3 weeks.For long term storage we recommend the addition of a carrier protein at 0.1%. Avoid repeated freeze/thaw cycles.
Source

Recombinants or rec. proteins
Group

recombinants

Gene target

2019 nCoV/COVID19 Nucleocapsid
Short name

2019 nCoV/COVID19 Nucleocapsid Recombinant
Technique

Recombinant, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. MyBioSource advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
Host

HEK cells
Alternative name

2019 nCoV/COVID19 Nucleocapsid Rec.
Alternative technique

rec

Name

Primary Cell Culture
Concept

Scope note: The initial culturing of cells derived directly from fresh TISSUES.
Tree numbers
- E01.370.225.500.223.500
- E05.200.500.265.500
- E05.242.223.500
- E05.481.500.249.500
Qualifiers

ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data